{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:39Z","timestamp":1786992399597,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1200105"],"award-info":[{"award-number":["2018YFC1200105"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jgar.2022.05.020","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T02:07:44Z","timestamp":1653962864000},"page":"56-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii"],"prefix":"10.1016","volume":"30","author":[{"given":"Yun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3620-0448","authenticated-orcid":false,"given":"Lanqing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2022.05.020_bib0001","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10096-019-03590-3","article-title":"Eravacycline, a newly approved fluorocycline","volume":"38","author":"Lee","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2022.05.020_bib0002","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.cmi.2015.11.004","article-title":"Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement","volume":"22","author":"Guan","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2022.05.020_bib0003","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41429-019-0188-6","article-title":"In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A.baumannii isolates","volume":"72","author":"Ozger","year":"2019","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jgar.2022.05.020_bib0004","series-title":"CLSI supplement M100","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2021"},{"key":"10.1016\/j.jgar.2022.05.020_bib0005","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0, 2022. http:\/\/www.eucast.org."},{"key":"10.1016\/j.jgar.2022.05.020_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2022.05.020_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01374-19","article-title":"Synergistic combinations and repurposed antibiotics active against the pandrug-resistant Klebsiella pneumoniae Nevada strain","volume":"63","author":"Brennan-Krohn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2022.05.020_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1179\/1973947814Y.0000000203","article-title":"In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Liu","year":"2015","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2022.05.020_bib0009","doi-asserted-by":"crossref","first-page":"651","DOI":"10.21037\/apm.2019.11.06","article-title":"Efficacy of tigecycline monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii sequence type 2 in Heilongjiang province","volume":"8","author":"Li","year":"2019","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jgar.2022.05.020_bib0010","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1089\/mdr.2016.0279","article-title":"In vitro activity of various antibiotics in combination with tigecycline against Acinetobacter baumannii: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2017","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2022.05.020_bib0011","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/1120009X.2018.1516270","article-title":"In-vitro activities of imipenem-colistin, imipenem-tigecycline, and tigecycline-colistin combinations against carbapenem-resistant Enterobacteriaceae","volume":"30","author":"Dundar","year":"2018","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2022.05.020_bib0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jmii.2016.12.008","article-title":"Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance","volume":"50","author":"Ku","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"10.1016\/j.jgar.2022.05.020_bib0013","first-page":"e1","article-title":"Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2022.05.020_bib0014","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant Gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716522001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:02:43Z","timestamp":1761991363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716522001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":14,"alternative-id":["S2213716522001230"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2022.05.020","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2022.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}